Speid Associates

Executive Summary

Speid & Associates is a specialized regulatory and clinical development consulting firm founded in 2004, headquartered in Toronto, Canada. The firm provides expert strategic regulatory affairs services to pharmaceutical and biotechnology companies, leveraging decades of industry experience to accelerate the approval of new therapies. Speid Associates navigates complex FDA and EMA processes, resolves clinical holds, and manages appeals, positioning itself as a trusted partner for companies seeking to bring new drugs to market efficiently. With a focus on drug delivery and AI/machine learning integration, the firm is well-suited to support innovative therapies in an increasingly competitive landscape. As a private consulting firm, Speid Associates does not disclose financials or specific client successes, but its long-standing presence and specialized expertise suggest a stable niche in the regulatory consulting market. The firm's ability to adapt to evolving regulatory standards and emerging technologies will be key to its continued relevance and growth.

Upcoming Catalysts (preview)

• TBDNew Client Engagements with AI-Driven Drug Developers70% success
• TBDAnnouncement of Major FDA Approval Facilitated by Speid50% success
• TBDExpansion of Services into New Therapeutic Areas60% success